Market Research Assistance

On the Web
Refine Result

By Date

Last Month
Last 3 Months
Last 6 Months
Last Year
Last 2 Years

By Price

< $1000
$1000-$2500
$2501-$4000
$4001-$5500
$5501-$7500
$7501-$9000
>$9000

Mental Illness Drugs Market Research Reports

Titlepublishedprice

Global Depression Drugs Market Research Report 2017

By QYResearch Group
"...... global market, with capacity, production, price, revenue and market share for each manufacturer, covering - Pfizer - Mylan - APOTEX - PRINSTON INC - TEVA - ROXANE - ZYDUS PHARMS - SUN PHARM......"
06-Jan-2017$2900

Major Depressive Disorder - Epidemiology Forecast To 2023

By Delve Insight
"...... epressive Disorder prevalent or incident cases segmented by age, sex and subpopulations. The Report also discusses the prevailing risk factors, disease burden with special emphasis on the unmet medical need associated with the Major Depressive Disord......"
01-Jan-2017$2750

Obsessive-Compulsive Disorder-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

By Delve Insight
"...... e-Compulsive Disorder Report is to understand the market and pipeline status of the drugs around the Obsessive-Compulsive Disorder to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designin......"
01-Jan-2017$2000

Schizophrenia - Market Insights, Epidemiology and Market Forecast-2023

By Delve Insight
"...... herapeutics market revenue; average cost of therapy, treatment practice and Schizophrenia forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Schizop......"
01-Jan-2017$4950

Bipolar disorder (BPD) - Market Insights, Epidemiology and Market Forecast-2023

By Delve Insight
"...... eport covers the therapeutics market revenue; average cost of therapy, treatment practice and Bipolar disorder (BPD) forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast......"
01-Jan-2017$4950

Risperdal Consta LP -Drug Insights, 2017

By Delve Insight
"...... otal sales estimation and also provides the Risperdal Consta LP sales performance during the historical period and forecast period to 2018. DelveInsight's Report also covers the detailed clinical assessment of Risperdal Consta LP, patents information......"
01-Jan-2017$1000

Psychosis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

By Delve Insight
"...... stand the market and pipeline status of the drugs around the Psychosis to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline startegies. The DelveInsight's Report provides th......"
01-Jan-2017$2000

Seroquel -Drug Insights, 2017

By Delve Insight
"...... ovides the Seroquel sales performance during the historical period and forecast period to 2018. DelveInsight's Report also covers the detailed clinical assessment of Seroquel, patents information and exclusivity data, route of synthesis, competitive ......"
01-Jan-2017$1000

Seroxat -Drug Insights, 2017

By Delve Insight
"...... des the Seroxat sales performance during the historical period and forecast period to 2018. DelveInsight's Report also covers the detailed clinical assessment of Seroxat, patents information and exclusivity data, route of synthesis, competitive lands......"
01-Jan-2017$1000

Cognitive Disorders-Pipeline Insights, 2017

By Delve Insight
"...... nical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA desig......"
01-Jan-2017$1250

Avail upto 50% Discount on below Publisher Reports.